LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | - | 27.8 | 329.3 | 77.1 | 8.7 | 0.1 | - | 442.9 |
1 | - | - | - | - | 1.3 | 59.8 | 26.5 | 1.8 | - | - | 89.4 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | - |
1 | - |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 8.6 |
1 | 19.6 |
Number of post synapses: 15945
Number of pre synapses: 3219
Number of output connections: 8807
Coverage factor: 1.7
Columnar completeness: 0.68
Area completeness: 0.71
Cell size (columns): 23
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#MeVP2 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Dm8a (R) | Glu | 2,535 | 70.4 | 16.2% | 16.2% |
1 | Dm8b (R) | Glu | 1,720 | 47.8 | 11.0% | 27.1% |
2 | Dm2 (R) | ACh | 1,482 | 41.2 | 9.5% | 36.6% |
3 | Cm1 (R) | ACh | 1,290 | 35.8 | 8.2% | 44.8% |
4 | Cm7 (R) | Glu | 1,214 | 33.7 | 7.7% | 52.6% |
5 | Cm3 (R) | GABA | 916 | 25.4 | 5.8% | 58.4% |
6 | Cm5 (R) | GABA | 877 | 24.4 | 5.6% | 64.0% |
7 | Cm8 (R) | GABA | 564 | 15.7 | 3.6% | 67.6% |
8 | MeVPMe7 (L) | Glu | 485 | 13.5 | 3.1% | 70.7% |
9 | Cm2 (R) | ACh | 389 | 10.8 | 2.5% | 73.2% |
10 | Cm34 (R) | Glu | 360 | 10.0 | 2.3% | 75.5% |
11 | Cm31b (R) | GABA | 304 | 8.4 | 1.9% | 77.4% |
12 | Mi10 (R) | ACh | 300 | 8.3 | 1.9% | 79.3% |
13 | Tm32 (R) | Glu | 202 | 5.6 | 1.3% | 80.6% |
14 | MeTu1 (R) | ACh | 165 | 4.6 | 1.1% | 81.7% |
15 | MeVC4b (L) | ACh | 150 | 4.2 | 1.0% | 82.6% |
16 | MeVP10 (R) | ACh | 135 | 3.8 | 0.9% | 83.5% |
17 | MeVC2 (L) | ACh | 133 | 3.7 | 0.8% | 84.3% |
18 | Pm4 (R) | GABA | 122 | 3.4 | 0.8% | 85.1% |
19 | Cm10 (R) | GABA | 115 | 3.2 | 0.7% | 85.8% |
20 | Cm11a (R) | ACh | 105 | 2.9 | 0.7% | 86.5% |
21 | aMe17e (R) | Glu | 104 | 2.9 | 0.7% | 87.2% |
22 | Tm29 (R) | Glu | 102 | 2.8 | 0.7% | 87.8% |
23 | MeVPMe13 (L) | ACh | 99 | 2.8 | 0.6% | 88.4% |
24 | Dm9 (R) | Glu | 86 | 2.4 | 0.5% | 89.0% |
25 | Cm4 (R) | Glu | 79 | 2.2 | 0.5% | 89.5% |
26 | MeVP41 (R) | ACh | 79 | 2.2 | 0.5% | 90.0% |
27 | aMe17b (R) | GABA | 74 | 2.1 | 0.5% | 90.5% |
28 | Cm26 (R) | Glu | 66 | 1.8 | 0.4% | 90.9% |
29 | Cm9 (R) | Glu | 63 | 1.8 | 0.4% | 91.3% |
30 | Cm29 (R) | GABA | 58 | 1.6 | 0.4% | 91.7% |
31 | OLVC2 (L) | GABA | 52 | 1.4 | 0.3% | 92.0% |
32 | Cm19 (R) | GABA | 46 | 1.3 | 0.3% | 92.3% |
33 | MeLo3b (R) | ACh | 42 | 1.2 | 0.3% | 92.6% |
34 | MeVP2 (R) | ACh | 42 | 1.2 | 0.3% | 92.8% |
35 | Cm11d (R) | ACh | 40 | 1.1 | 0.3% | 93.1% |
36 | Tm5b (R) | ACh | 39 | 1.1 | 0.2% | 93.3% |
37 | MeLo4 (R) | ACh | 36 | 1.0 | 0.2% | 93.6% |
38 | MeVC22 (R) | Glu | 36 | 1.0 | 0.2% | 93.8% |
instance | NT | total connections | connections /#MeVP2 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Tm36 (R) | ACh | 914 | 25.4 | 10.3% | 10.3% |
1 | Cm15 (R) | GABA | 857 | 23.8 | 9.7% | 20.0% |
2 | TmY17 (R) | ACh | 711 | 19.8 | 8.0% | 28.1% |
3 | Cm7 (R) | Glu | 610 | 16.9 | 6.9% | 35.0% |
4 | Tm38 (R) | ACh | 492 | 13.7 | 5.6% | 40.5% |
5 | Cm3 (R) | GABA | 398 | 11.1 | 4.5% | 45.0% |
6 | Cm31b (R) | GABA | 386 | 10.7 | 4.4% | 49.4% |
7 | Tm37 (R) | Glu | 279 | 7.8 | 3.2% | 52.6% |
8 | MeVP10 (R) | ACh | 250 | 6.9 | 2.8% | 55.4% |
9 | Cm5 (R) | GABA | 200 | 5.6 | 2.3% | 57.6% |
10 | Tm32 (R) | Glu | 198 | 5.5 | 2.2% | 59.9% |
11 | MeLo3a (R) | ACh | 196 | 5.4 | 2.2% | 62.1% |
12 | Cm19 (R) | GABA | 182 | 5.1 | 2.1% | 64.2% |
13 | Tm40 (R) | ACh | 171 | 4.8 | 1.9% | 66.1% |
14 | MeVP41 (R) | ACh | 152 | 4.2 | 1.7% | 67.8% |
15 | TmY13 (R) | ACh | 145 | 4.0 | 1.6% | 69.4% |
16 | MeVPMe7 (R) | Glu | 143 | 4.0 | 1.6% | 71.1% |
17 | MeVP27 (R) | unclear | 141 | 3.9 | 1.6% | 72.7% |
18 | Cm8 (R) | GABA | 133 | 3.7 | 1.5% | 74.2% |
19 | MeVP30 (R) | ACh | 97 | 2.7 | 1.1% | 75.3% |
20 | Tm16 (R) | ACh | 86 | 2.4 | 1.0% | 76.2% |
21 | Tm30 (R) | GABA | 79 | 2.2 | 0.9% | 77.1% |
22 | Cm29 (R) | GABA | 78 | 2.2 | 0.9% | 78.0% |
23 | Tm29 (R) | Glu | 70 | 1.9 | 0.8% | 78.8% |
24 | MeVP6 (R) | Glu | 69 | 1.9 | 0.8% | 79.6% |
25 | Cm11b (R) | ACh | 64 | 1.8 | 0.7% | 80.3% |
26 | Dm8b (R) | Glu | 57 | 1.6 | 0.6% | 80.9% |
27 | MeVP63 (R) | GABA | 57 | 1.6 | 0.6% | 81.6% |
28 | MeVPMe7 (L) | Glu | 57 | 1.6 | 0.6% | 82.2% |
29 | Mi16 (R) | GABA | 56 | 1.6 | 0.6% | 82.9% |
30 | Dm8a (R) | Glu | 55 | 1.5 | 0.6% | 83.5% |
31 | aMe9 (R) | ACh | 52 | 1.4 | 0.6% | 84.1% |
32 | Pm4 (R) | GABA | 51 | 1.4 | 0.6% | 84.7% |
33 | Cm31a (R) | GABA | 50 | 1.4 | 0.6% | 85.2% |
34 | Cm17 (R) | GABA | 44 | 1.2 | 0.5% | 85.7% |
35 | MeVPMe13 (R) | ACh | 44 | 1.2 | 0.5% | 86.2% |
36 | Tm31 (R) | Glu | 44 | 1.2 | 0.5% | 86.7% |
37 | MeVP2 (R) | ACh | 42 | 1.2 | 0.5% | 87.2% |
38 | MeLo4 (R) | ACh | 37 | 1.0 | 0.4% | 87.6% |
39 | Tm39 (R) | ACh | 37 | 1.0 | 0.4% | 88.0% |
40 | TmY10 (R) | ACh | 37 | 1.0 | 0.4% | 88.4% |
41 | Cm10 (R) | GABA | 36 | 1.0 | 0.4% | 88.8% |